Y-Intercept (HK)’s ImageneBio Inc IMA Stock Holding History

Y-Intercept (HK)’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,052	Closed	-$100K	–	1536
2024 Q2	$100K	Buy	+5,052	New	+$89.2K	0.01%	1256

Other funds holding IMA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return

Y-Intercept (HK)'s IMA Position: Q3 2024 in Review

Y-Intercept (HK) sold out of ImageneBio Inc (IMA) in Q3 2024, closing a stake of 5,052 shares — an estimated $100K sold.

Y-Intercept (HK) first reported a position in IMA in Q2 2024 and held it in 1 quarter. The position peaked at $100K in Q2 2024. 57 funds tracked by Wall St. Rank hold IMA as of Q3 2024.

Y-Intercept (HK) reported no remaining ImageneBio Inc position as of Q3 2024 after selling out during the quarter.
Y-Intercept (HK) sold 5,052 ImageneBio Inc shares in Q3 2024, an estimated $100K.
Y-Intercept (HK) first reported a position in ImageneBio Inc in Q2 2024 and held it in 1 quarter.
Y-Intercept (HK)'s ImageneBio Inc position peaked at $100K in Q2 2024.
57 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.